Generating induced pluripotent stem cell derived endothelial cells and induced endothelial cells for cardiovascular disease modelling and therapeutic angiogenesis

International Journal of Cardiology

Volumn 197, Issue , 2015, Pages 116-122

  Clayton, Z E ^a,b   Sadeghipour, S ^a   Patel, S ^a,b,c  

^a HEART RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Angiogenesis; Cell therapies; Endothelial cells; Induced pluripotent stem cells; Peripheral vascular disease; Reprogramming

Indexed keywords

FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; KRUPPEL LIKE FACTOR 4; RECOMBINANT VASCULOTROPIN; SCATTER FACTOR; TRANSCRIPTION FACTOR; VASCULOTROPIN;

ACETYLATION; ANGINA PECTORIS; ANGIOGENESIS; ANKLE BRACHIAL INDEX; ARTICLE; BLOOD FLOWMETRY; CARDIOVASCULAR DISEASE; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL RENEWAL; ENDOTHELIUM CELL; EPIGENETICS; EPITHELIUM CELL; GENE OVEREXPRESSION; HEART INFARCTION; HUMAN; LIMB ISCHEMIA; NONHUMAN; NUCLEAR REPROGRAMMING; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; QUALITY OF LIFE; SOMATIC CELL; STEM CELL TRANSPLANTATION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; ANIMAL; CARDIOVASCULAR DISEASES; CELL CULTURE; CYTOLOGY; INDUCED PLURIPOTENT STEM CELL; PHYSIOLOGY; PROCEDURES;

ANIMALS; CARDIOVASCULAR DISEASES; CELL DIFFERENTIATION; CELLS, CULTURED; ENDOTHELIAL CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; STEM CELL TRANSPLANTATION;

EID: 84938503232     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.06.038     Document Type: Review

References (97)

1. K. Ouriel Peripheral arterial disease The Lancet 358 9289 2001 1257 1264
2. G.P. Fadini, C. Agostini, and A. Avogaro Autologous stem cell therapy for peripheral arterial disease meta-analysis and systematic review of the literature Atherosclerosis 209 1 2010 10 17
3. I. Zachary, and R.D. Morgan Therapeutic angiogenesis for cardiovascular disease: biological context, challenges, prospects Heart 97 3 2011 181 189
4. K.D. Choi, J. Yu, K. Smuga-Otto, G. Salvagiotto, W. Rehrauer, M. Vodyanik, and et al. Hematopoietic and endothelial differentiation of human induced pluripotent stem cells Stem Cells 27 3 2009 559 567
5. D. Taura, M. Sone, K. Homma, N. Oyamada, K. Takahashi, N. Tamura, and et al. Induction and isolation of vascular cells from human induced pluripotent stem cells - brief report Arterioscler. Thromb. Vasc. Biol. 29 7 2009 1100 1103
6. A.J. Rufaihah, N.F. Huang, S. Jame, J.C. Lee, H.N. Nguyen, B. Byers, and et al. Endothelial cells derived from human iPSCS increase capillary density and improve perfusion in a mouse model of peripheral arterial disease Arterioscler. Thromb. Vasc. Biol. 31 11 2011 e72 e79
7. J. Li, N.F. Huang, J. Zou, T.J. Laurent, J.C. Lee, J. Okogbaa, and et al. Conversion of human fibroblasts to functional endothelial cells by defined factors Arterioscler. Thromb. Vasc. Biol. 33 6 2013 1366 1375
8. A. Margariti, B. Winkler, E. Karamariti, A. Zampetaki, T.-n. Tsai, and D. Baban Direct reprogramming of fibroblasts into endothelial cells capable of angiogenesis and reendothelialization in tissue-engineered vessels Proc. Natl. Acad. Sci. 109 34 2012 13793 13798
9. S. Takeshita, L.P. Zheng, E. Brogi, M. Kearney, L.Q. Pu, S. Bunting, and et al. Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model J. Clin. Invest. 93 2 1994 662 670
10. J.J. Lopez, R.J. Laham, A. Stamler, J.D. Pearlman, S. Bunting, A. Kaplan, and et al. VEGF Administration in Chronic Myocardial Ischemia in Pigs 11-01-1998 (00:00:00. 272-81 pp.)
11. A. Rivard, M. Silver, D. Chen, M. Kearney, M. Magner, B. Annex, and et al. Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF Am. J. Pathol. 154 2 1999 355 363
12. Y. Li, S. Hazarika, D. Xie, A.M. Pippen, C.D. Kontos, and B.H. Annex In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia Diabetes 56 3 2007 656 665
13. B. Schumacher, P. Pecher, B.U. von Specht, and T. Stegmann Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease Circulation 97 7 1998 645 650
14. R.C. Hendel, T.D. Henry, K. Rocha-Singh, J.M. Isner, D.J. Kereiakes, F.J. Giordano, and et al. Effect of intracoronary recombinant human vascular endothelial growth factor on myocardial perfusion: evidence for a dose-dependent effect Circulation 101 2 2000 118 121
15. M. Simons, B.H. Annex, R.J. Laham, N. Kleiman, T. Henry, H. Dauerman, and et al. Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial Circulation 105 7 2002 788 793
16. T.K. Rosengart, L.Y. Lee, S.R. Patel, T.A. Sanborn, M. Parikh, G.W. Bergman, and et al. Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease Circulation 100 5 1999 468 474
17. J.F. Symes, D.W. Losordo, P.R. Vale, K.G. Lathi, D.D. Esakof, M. Mayskiy, and et al. Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease Ann. Thorac. Surg. 68 3 1999 830 836
18. I. Baumgartner, A. Pieczek, O. Manor, R. Blair, M. Kearney, K. Walsh, and et al. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia Circulation 97 12 1998 1114 1123
19. K.-G. Shyu, H. Chang, B.-W. Wang, and P. Kuan Intramuscular vascular endothelial growth factor gene therapy in patients with chronic critical leg ischemia Am. J. Med. 114 2 2003 85 92
20. J.M. Isner, A. Pieczek, R. Schainfeld, R. Blair, L. Haley, T. Asahara, and et al. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb The Lancet. 348 9024 1996 370 374
21. Y.H. Kusumanto, V. van Weel, N.H. Mulder, A.J. Smit, J.J.A.M. van den Dungen, J.M.M. Hooymans, and et al. Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind randomized trial Hum. Gene Ther. 17 6 2006 683 691
22. S. Nikol, I. Baumgartner, E. Van Belle, C. Diehm, A. Visona, M.C. Capogrossi, and et al. Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischemia Mol. Ther. 16 5 2008 972 978
23. R.J. Powell, M. Simons, F.O. Mendelsohn, G. Daniel, T.D. Henry, M. Koga, and et al. Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia Circulation 118 1 2008 58 65
24. R.J. Powell, P. Goodney, F.O. Mendelsohn, E.K. Moen, and B.H. Annex Safety and efficacy of patient specific intramuscular injection of HGF plasmid gene therapy on limb perfusion and wound healing in patients with ischemic lower extremity ulceration: results of the HGF-0205 trial J. Vasc. Surg. 52 6 2010 1525 1530
25. H. Shigematsu, K. Yasuda, T. Iwai, T. Sasajima, S. Ishimaru, Y. Ohashi, and et al. Randomized, double-blind, placebo-controlled clinical trial of hepatocyte growth factor plasmid for critical limb ischemia Gene Ther. 17 9 2010 1152 1161
26. J. Belch, W.R. Hiatt, I. Baumgartner, I.V. Driver, S. Nikol, L. Norgren, and et al. Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia The Lancet 377 9781 2011 1929 1937
27. B. Assmus Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI) Circulation 106 24 2002 3009 3017
28. K.C. Wollert, G.P. Meyer, J. Lotz, S. Ringes Lichtenberg, P. Lippolt, C. Breidenbach, and et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial The Lancet 364 9429 2004 141 148
29. K. Yamahara, M. Sone, H. Itoh, J.K. Yamashita, T. Yurugi-Kobayashi, K. Homma, and et al. Augmentation of neovascularizaiton in hindlimb ischemia by combined transplantation of human embryonic stem cells-derived endothelial and mural cells PLoS One 3 2 2008 e1666
30. K.S. Volz, E. Miljan, A. Khoo, and J.P. Cooke Development of pluripotent stem cells for vascular therapy Vascul. Pharmacol. 56 5-6 2012 288 296
31. D.P. Sieveking, and M.K. Ng Cell therapies for therapeutic angiogenesis: back to the bench Vasc. Med. 14 2 2009 153 166
32. N.J. Leeper, A.L. Hunter, and J.P. Cooke Stem cell therapy for vascular regeneration: adult, embryonic, and induced pluripotent stem cells Circulation 122 5 2010 517 526
33. K. Takahashi, and S. Yamanaka Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors Cell 126 4 2006 663 676
34. S.X.L. Huang, M.N. Islam, J. O'Neill, Z. Hu, Y.-G. Yang, Y.-W. Chen, and et al. Efficient generation of lung and airway epithelial cells from human pluripotent stem cells Nat. Biotechnol. 32 1 2014 84 91
35. D. Castelvecchi Nature newsblog [Internet]: nature [cited 2014]. Available from: http://blogs.nature.com/news/2013/07/japan-to-start-stem-cell-study-on-humans.html 2013
36. M. Koyanagi-Aoi, M. Ohnuki, K. Takahashi, K. Okita, H. Noma, Y. Sawamura, and et al. Differentiation-defective phenotypes revealed by large-scale analyses of human pluripotent stem cells Proc. Natl. Acad. Sci. 110 51 2013 20569 20574
37. K. Tanabe, M. Nakamura, M. Narita, K. Takahashi, and S. Yamanaka Maturation, not initiation, is the major roadblock during reprogramming toward pluripotency from human fibroblasts Proc. Natl. Acad. Sci. 110 30 2013 12172 12179
38. M. Nakagawa, M. Koyanagi, K. Tanabe, K. Takahashi, T. Ichisaka, T. Aoi, and et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts Nat. Biotechnol. 26 1 2008 101 106
39. Y. Buganim, S. Markoulaki, N. van Wietmarschen, H. Hoke, T. Wu, K. Ganz, and et al. The developmental potential of iPSCs is greatly influenced by reprogramming factor selection Cell Stem Cell 15 3 2014 295 309
40. K. Okita, T. Ichisaka, and S. Yamanaka Generation of germline-competent induced pluripotent stem cells Nature 448 7151 2007 313 317
41. J. Yu, M.A. Vodyanik, K. Smuga-Otto, J. Antosiewicz-Bourget, J.L. Frane, S. Tian, and et al. Induced pluripotent stem cell lines derived from human somatic cells Science 318 5858 2007 1917 1920
42. M. Stadtfeld, and K. Hochedlinger Induced pluripotency: history, mechanisms, and applications Genes Dev. 24 20 2010 2239 2263
43. T.S. Mikkelsen, J. Hanna, X. Zhang, M. Ku, M. Wernig, P. Schorderet, and et al. Dissecting direct reprogramming through integrative genomic analysis Nature 454 7200 2008 49 55
44. K. Okita, M. Nakagawa, H. Hyenjong, T. Ichisaka, and S. Yamanaka Generation of mouse induced pluripotent stem cells without viral vectors Science 322 5903 2008 949 953
45. K. Kaji, K. Norrby, A. Paca, M. Mileikovsky, P. Mohseni, and K. Woltjen Virus-free induction of pluripotency and subsequent excision of reprogramming factors Nature 458 7239 2009 771 775
46. L. Warren, P.D. Manos, T. Ahfeldt, Y.H. Loh, H. Li, F. Lau, and et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA Cell Stem Cell 7 5 2010 618 630
47. E. Yakubov, G. Rechavi, S. Rozenblatt, and D. Givol Reprogramming of human fibroblasts to pluripotent stem cells using mRNA of four transcription factors Biochem. Biophys. Res. Commun. 394 1 2010 189 193
48. K. Drews, G. Tavernier, J. Demeester, H. Lehrach, S.C. De Smedt, J. Rejman, and et al. The cytotoxic and immunogenic hurdles associated with non-viral mRNA-mediated reprogramming of human fibroblasts Biomaterials 33 16 2012 4059 4068
49. P. Hou, Y. Li, X. Zhang, C. Liu, J. Guan, H. Li, and et al. Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds Science 341 6146 2013 651 654
50. M. Stadtfeld, N. Maherali, and K. Hochedlinger Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse Cell Stem Cell 2 3 2008 230 240
51. J. Hanna, K. Saha, B. Pando, J. van Zon, C.J. Lengner, M.P. Creyghton, and et al. Direct cell reprogramming is a stochastic process amenable to acceleration Nature 462 7273 2009 595 601
52. D. Huangfu, R. Maehr, W. Guo, A. Eijkelenboom, M. Snitow, A.E. Chen, and et al. Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds Nat. Biotechnol. 26 7 2008 795 797
53. K. Drews, J. Jozefczuk, A. Prigione, and J. Adjaye Human induced pluripotent stem cells - from mechanisms to clinical applications J. Mol. Med. 90 7 2012 735 745
54. J.K. Ichida, J. Blanchard, K. Lam, E.Y. Son, J.E. Chung, D. Egli, and et al. A small-molecule inhibitor of Tgf-β signaling replaces Sox2 in reprogramming by inducing nanog Cell Stem Cell 5 5 2009 491 503
55. K. Woltjen, and W.L. Stanford Inhibition of Tgf-β signaling improves mouse fibroblast reprogramming Cell Stem Cell 5 5 2009 457 458
56. K. Takahashi, K. Tanabe, M. Ohnuki, M. Narita, A. Sasaki, M. Yamamoto, and et al. Induction of pluripotency in human somatic cells via a transient state resembling primitive streak-like mesendoderm Nat. Commun. 5 2014
57. T. Shinagawa, T. Takagi, D. Tsukamoto, C. Tomaru, L.M. Huynh, P. Sivaraman, and et al. Histone variants enriched in oocytes enhance reprogramming to induced pluripotent stem cells Cell Stem Cell 14 2 2014 217 227
58. W. Carey Bryce, S. Markoulaki, H. Hanna Jacob, A. Faddah Dina, Y. Buganim, J. Kim, and et al. Reprogramming factor stoichiometry influences the epigenetic state and biological properties of induced pluripotent stem cells Cell Stem Cell 9 6 2011 588 598
59. U. Tiemann, M. Sgodda, E. Warlich, M. Ballmaier, H.R. Schöler, A. Schambach, and et al. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells Cytometry A 79A 6 2011 426 435
60. K.S. Tan, K. Tamura, M.I. Lai, A. Veerakumarasivam, Y. Nakanishi, M. Ogawa, and et al. Molecular pathways governing development of vascular endothelial cells from ES/iPS cells Stem Cell Rev. 9 5 2013 586 598
61. N.L. Boyd, S.K. Dhara, R. Rekaya, E.A. Godbey, K. Hasneen, R.R. Rao, and et al. BMP4 promotes formation of primitive vascular networks in human embryonic stem cell-derived embryoid bodies Exp. Biol. Med. 232 6 2007 833 843
62. D. James, H.-s. Nam, M. Seandel, D. Nolan, T. Janovitz, M. Tomishima, and et al. Expansion and maintenance of human embryonic stem cell-derived endothelial cells by TGF[beta] inhibition is Id1 dependent Nat. Biotechnol. 28 2 2010 161 166
63. S. Zhang, J.R. Dutton, L. Su, J. Zhang, and L. Ye The influence of a spatiotemporal 3D environment on endothelial cell differentiation of human induced pluripotent stem cells Biomaterials 35 12 2014 3786 3793
64. V.V. Orlova, F.E. van den Hil, S. Petrus-Reurer, Y. Drabsch, P. Ten Dijke, and C.L. Mummery Generation, expansion and functional analysis of endothelial cells and pericytes derived from human pluripotent stem cells Nat. Protoc. 9 6 2014 1514 1531
65. V.V. Orlova, Y. Drabsch, C. Freund, S. Petrus-Reurer, F.E. van den Hil, S. Muenthaisong, and et al. Functionality of endothelial cells and pericytes from human pluripotent stem cells demonstrated in cultured vascular plexus and zebrafish xenografts Arterioscler. Thromb. Vasc. Biol. 34 1 2014 177 186
66. N. Prasain, M.R. Lee, S. Vemula, J.L. Meador, M. Yoshimoto, M.J. Ferkowicz, and et al. Differentiation of human pluripotent stem cells to cells similar to cord-blood endothelial colony-forming cells Nat. Biotechnol. 32 11 2014 1151 1157
67. K. Kim, A. Doi, B. Wen, K. Ng, R. Zhao, P. Cahan, and et al. Epigenetic memory in induced pluripotent stem cells Nature 467 7313 2010 285 290
68. K. Kim, R. Zhao, A. Doi, K. Ng, J. Unternaehrer, P. Cahan, and et al. Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells Nat. Biotechnol. 29 12 2011 1117 1119
69. G. Liang, and Y. Zhang Genetic and epigenetic variations in iPSCs: potential causes and implications for application Cell Stem Cell 13 2 2013 149 159
70. N. Maherali, R. Sridharan, W. Xie, J. Utikal, S. Eminli, K. Arnold, and et al. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution Cell Stem Cell 1 1 2007 55 70
71. D. Taura, M. Noguchi, M. Sone, K. Hosoda, E. Mori, Y. Okada, and et al. Adipogenic differentiation of human induced pluripotent stem cells: comparison with that of human embryonic stem cells FEBS Lett. 583 6 2009 1029 1033
72. J. Xi, M. Khalil, N. Shishechian, T. Hannes, K. Pfannkuche, H. Liang, and et al. Comparison of contractile behavior of native murine ventricular tissue and cardiomyocytes derived from embryonic or induced pluripotent stem cells FASEB J. 24 8 2010 2739 2751
73. Y. Tokumoto, S. Ogawa, T. Nagamune, and J. Miyake Comparison of efficiency of terminal differentiation of oligodendrocytes from induced pluripotent stem cells versus embryonic stem cells in vitro J. Biosci. Bioeng. 109 6 2010 622 628
74. C.A. Staton, M.W.R. Reed, and N.J. Brown A critical analysis of current in vitro and in vivo angiogenesis assays Int. J. Exp. Pathol. 90 3 2009 195 221
75. D. Belair, J. Whisler, J. Valdez, J. Velazquez, J. Molenda, V. Vickerman, and et al. Human vascular tissue models formed from human induced pluripotent stem cell derived endothelial cells Stem Cell Rev. Rep. 2014 1 15
76. W.J. Adams, Y. Zhang, J. Cloutier, P. Kuchimanchi, G. Newton, S. Sehrawat, and et al. Functional vascular endothelium derived from human induced pluripotent stem cells Stem Cell Rep. 1 2 2013 105 113
77. R. Samuel, L. Daheron, S. Liao, T. Vardam, W.S. Kamoun, A. Batista, and et al. Generation of functionally competent and durable engineered blood vessels from human induced pluripotent stem cells Proc. Natl. Acad. Sci. 110 31 2013 12774 12779
78. X. Carvajal-Vergara, A. Sevilla, S.L. D'Souza, Y.S. Ang, C. Schaniel, D.F. Lee, and et al. Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome Nature 465 7299 2010 808 812
79. C. Kim, J. Wong, J. Wen, S. Wang, C. Wang, S. Spiering, and et al. Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs Nature 494 7435 2013 105 110
80. A. Moretti, M. Bellin, A. Welling, C.B. Jung, J.T. Lam, L. Bott-Flügel, and et al. Patient-specific induced pluripotent stem-cell models for long-QT syndrome N. Engl. J. Med. 363 15 2010 1397 1409
81. N. Egawa, S. Kitaoka, K. Tsukita, M. Naitoh, K. Takahashi, T. Yamamoto, and et al. Drug screening for ALS using patient-specific induced pluripotent stem cells Sci. Transl. Med. 4 145 2012 (145ra04-ra04)
82. J.A. Efe, S. Hilcove, J. Kim, H. Zhou, K. Ouyang, G. Wang, and et al. Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy Nat. Cell Biol. 13 3 2011 215 222
83. M. Ginsberg, D. James, B.-S. Ding, D. Nolan, F. Geng, M. Butler Jason, and et al. Efficient direct reprogramming of mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression Cell 151 3 2012 559 575
84. Y. Zhou, F. Yang, T. Chen, Y. Wu, M. Yang, J. Zhu, and et al. An updated view on the differentiation of stem cells into endothelial cells Sci. China Life Sci. 57 8 2014 763 773
85. S. De Val, and B.L. Black Transcriptional control of endothelial cell development Dev. Cell 16 2 2009 180 195
86. R. Morita, M. Suzuki, H. Kasahara, N. Shimizu, T. Shichita, T. Sekiya, and et al. ETS transcription factor ETV2 directly converts human fibroblasts into functional endothelial cells Proc. Natl. Acad. Sci. 112 1 2015 160 165
87. X. Li, J. Yuan, W. Li, S. Liu, M. Hua, X. Lu, and et al. Direct differentiation of homogeneous human adipose stem cells into functional hepatocytes by mimicking liver embryogenesis J. Cell. Physiol. 229 6 2014 801 812
88. Y.J. Kim, H. Lim, Z. Li, Y. Oh, I. Kovlyagina, I.Y. Choi, and et al. Generation of multipotent induced neural crest by direct reprogramming of human postnatal fibroblasts with a single transcription factor Cell Stem Cell 15 4 2014 497 506
89. J. Liu, Y. Liu, H. Wang, H. Hao, Q. Han, J. Shen, and et al. Direct differentiation of hepatic stem-like WB cells into insulin-producing cells using small molecules Sci. Rep. 3 2013 1185
90. A.S. Lee, D. Xu, J.R. Plews, P.K. Nguyen, D. Nag, J.K. Lyons, and et al. Preclinical derivation and imaging of autologously transplanted canine induced pluripotent stem cells J. Biol. Chem. 286 37 2011 32697 32704
91. M. Gu, P.K. Nguyen, A.S. Lee, D. Xu, S. Hu, J.R. Plews, and et al. Microfluidic single-cell analysis shows that porcine induced pluripotent stem cell-derived endothelial cells improve myocardial function by paracrine activation Circ. Res. 111 7 2012 882 893
92. C. Templin, R. Zweigerdt, K. Schwanke, R. Olmer, J.R. Ghadri, M.Y. Emmert, and et al. Transplantation and tracking of human-induced pluripotent stem cells in a pig model of myocardial infarction: assessment of cell survival, engraftment, and distribution by hybrid single photon emission computed tomography/computed tomography of sodium iodide symporter transgene expression Circulation 126 4 2012 430 439
93. W.-H. Lai, J.C.Y. Ho, Y.-C. Chan, J.H.L. Ng, K.-W. Au, L.-Y. Wong, and et al. Attenuation of hind-limb ischemia in mice with endothelial-like cells derived from different sources of human stem cells PLoS One 8 3 2013 e57876
94. G.L. Boulting, E. Kiskinis, G.F. Croft, M.W. Amoroso, D.H. Oakley, B.J. Wainger, and et al. A functionally characterized test set of human induced pluripotent stem cells Nat. Biotechnol. 29 3 2011 279 286
95. J.P. Cooke Therapeutic transdifferentiation: a novel approach for vascular disease Circ. Res. 112 5 2013 748 750
96. N.F. Huang, R.E. Dewi, J. Okogbaa, J.C. Lee, A. Rufaihah, S.C. Heilshorn, and et al. Chemotaxis of human induced pluripotent stem cell-derived endothelial cells Am. J. Transl. Res. 5 5 2013 510 520
97. H. Zheng, G. Fu, T. Dai, and H. Huang Migration of endothelial progenitor cells mediated by stromal cell-derived factor-1α/CXCR4 via PI3K/Akt/eNOS signal transduction pathway J. Cardiovasc. Pharmacol. 50 3 2007